Epigenetic Therapy Leaps Ahead With Specific Targeting of EZH2

Cancer Cell - United States
doi 10.1016/j.ccr.2012.10.016
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV